TEK

TEK receptor tyrosine kinase

The TEK gene (also called the TIE2 gene) provides instructions for making a protein called TEK receptor tyrosine kinase. The TEK receptor tyrosine kinase (or TEK receptor) is active (expressed) mainly in endothelial cells, which line the walls of blood vessels. When the TEK receptor is activated, it triggers a series of chemical signals that facilitates communication between endothelial cells and smooth muscle cells. Layers of smooth muscle cells surround layers of endothelial cells lining the walls of blood vessels. Communication between these two cell types is necessary to direct blood vessel formation (angiogenesis) and ensure the structure and integrity of blood vessels.

The TEK receptor is also found in bone marrow, where it is expressed in blood-forming cells called hematopoietic stem cells. The role of the TEK receptor in hematopoietic stem cells is unknown. Researchers speculate that the TEK receptor aids in hematopoietic stem cell growth and division (proliferation) or cell specialization (differentiation).

At least eight mutations in the TEK gene have been found to cause multiple cutaneous and mucosal venous malformations (also known as VMCM). These mutations change single protein building blocks (amino acids) in the TEK receptor tyrosine kinase. The most common mutation replaces the amino acid arginine with the amino acid tryptophan at position 849 in the TEK receptor (written as Arg849Trp or R849W). The R849W mutation and most of the others that cause this condition result in a TEK receptor that is always turned on (overactive).

An overactive TEK receptor is thought to disrupt the communication between endothelial cells and smooth muscle cells. It is unclear how a lack of communication between these cells causes venous malformations. These abnormal blood vessels show a deficiency of smooth muscle cells while endothelial cells are maintained. Venous malformations cause lesions below the surface of the skin or mucous membranes, which are characteristic of VMCM.

Cytogenetic Location: 9p21, which is the short (p) arm of chromosome 9 at position 21

Molecular Location: base pairs 27,109,141 to 27,230,178 on chromosome 9 (Homo sapiens Annotation Release 108, GRCh38.p7) (NCBI)

Cytogenetic Location: 9p21, which is the short (p) arm of chromosome 9 at position 21
  • CD202B
  • soluble TIE2 variant 1
  • soluble TIE2 variant 2
  • TEK tyrosine kinase, endothelial
  • TEK tyrosine kinase, endothelial precursor
  • TIE-2
  • TIE2